E10.359
Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema
Clinical Classification Guidelines
Medical Intelligence & Overview
Type 1 diabetes mellitus is a chronic condition where the body's immune system mistakenly attacks the insulin-producing cells in the pancreas. This leads to elevated blood sugar levels, which can affect various organs and tissues. A serious complication associated with this condition is proliferative diabetic retinopathy, a form of eye damage that can threaten vision. The specific ICD-10 code E10.359 refers to cases where proliferative diabetic retinopathy is present without macular edema, indicating advanced retinal changes without swelling in the central part of the retina.
Causes & Symptoms
Clinical Causes: Autoimmune destruction of insulin-producing cells in the pancreas Genetic predisposition Environmental factors triggering immune responses Poorly controlled blood sugar levels over time
Key Symptoms: Gradual loss of vision Seeing floaters or spots in the visual field Blurred vision that worsens over time Difficulty perceiving colors or contrast Possible blind spots developing in the visual field
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves comprehensive eye examinations, including dilated retinal exams to assess the extent of retinal damage. Eye imaging techniques like fluorescein angiography can visualize abnormal blood vessels and areas of neovascularization (growth of new, fragile blood vessels). Blood tests help confirm diabetes control and monitor related health metrics. Regular screening is vital for early detection of diabetic eye complications, especially in patients with long-standing or poorly managed diabetes.
Treatment Protocols: Management aims to slow or halt disease progression and preserve vision. Key treatment options include: - **Blood sugar control:** Maintaining stable blood glucose levels through insulin therapy, diet, and lifestyle modifications. - **Laser therapy:** Pan-retinal photocoagulation (laser treatment) to shrink abnormal blood vessels and prevent bleeding. - **Anti-VEGF injections:** Medications that inhibit growth of new blood vessels, used in some cases. - **Regular eye examinations:** To monitor disease progression and adjust treatments as necessary. - **Managing associated health conditions:** Controlling blood pressure and cholesterol to reduce additional risks. It is important to work closely with healthcare providers to tailor treatment plans to individual needs and to ensure regular follow-up.
Clinical Advice & FAQs
Billing Guidance
Is E10.359 a billable ICD-10 code?
Yes, E10.359 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E10.359?
Clinical documentation must specify the nature of Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema and any associated comorbidities for accurate reporting.
Cite this Clinical Reference